Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma

Recruiting now · Not applicable

Conditions studied: Malignant Pleural Mesothelioma

In brief

The researchers are doing this study to test the ability of a new technology called breathprinting, or electronic nose (E-Nose), to measure how people respond to standard treatment for malignant pleural mesothelioma (MPM). The researchers will study how E-Nose breathprints change over time as people receive standard treatment for MPM. They will also look at how changes in people's E-Nose breathprints compare to changes in their standard imaging scans and in biomarkers of MPM in their blood.

Key facts

Study ID
NCT06037941
Run by
Memorial Sloan Kettering Cancer Center
People needed
20
Starts
2023-09-08
Expected to finish
2026-09-01
Last updated by the study team
2025-09-22

Who can join

Age: 30 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.